玻璃体腔内注射康柏西普治疗视网膜静脉阻塞的围手术期护理干预效果

Perioperative Nursing Intervention Effect of Intravitreal Injection of Conbercept in the Treatment of Retinal Vein Occlusion

目的探讨视网膜阻塞采用玻璃体腔内注射康柏西普治疗的护理方法与效果。方法随机将方便选取的2017年3月—2018年6月期间该院收治的98例视网膜静脉阻塞患者分为两组,每组49例,两组均采用玻璃腔内注射康柏西普治疗,其中对照组行常规护理,观察组行针对性护理,对两组护理效果进行比较。结果干预前,两组的各项评分比较差异无统计学意义(P>0.05);干预后,观察组的SDS和SAS评分均分别为(32.5±4.1)分、(33.2±4.5)分,明显低于对照组的(45.5±4.3)分、(43.8±3.3)分,组间比较差异有统计学意义(t=15.316、13.297,P<0.05);观察组和对照组的并发症发生率分别为6.12%、20.41%,组间比较差异有统计学意义(χ^(2)=4.346,P<0.05);同时,观察组的护理满意度为97.96%,明显高于对照组的81.63%,组间对比差异有统计学意义(χ^(2)=7.127,P<0.05)。结论临床上运用玻璃体腔内注射康柏西普对视网膜静脉阻塞患者进行治疗时,再给予针对性护理,可以获得较好的效果。

Objective To explore the nursing methods and effects of intravitreal injection of Conbercept for retinal occlusion.Methods Randomly divide 98 patients with retinal vein occlusion in the hospital who were conveniently selected from March 2017 to June 2018 into two groups,49 cases in each group.Both groups were treated with intravitreal injection of Conbercept,among which the control group underwent routine nursing,while observation group underwent targeted nursing,and the nursing effects of the two groups were compared.Results Before the intervention,there was not statistically significant in the scores of the two groups(P>0.05);after the intervention,the SDS and SAS scores of the observation group were(32.5±4.1)points and(33.2±4.5)points respectively,which were significantly lower than those of the control group of(45.5±4.3)points and(43.8±3.3)points,and the difference was statistically significant(t=15.316,13.297,P<0.05);the complication rate of the observation group and the control group was 6.12%and 20.41%,respectively.The difference between the groups was statistically significant(χ^(2)=4.346,P<0.05);meanwhile,the nursing satisfaction of the observation group was 97.96%,which was significantly higher than 81.63%of the control group.The difference between the groups was statistically significant(χ^(2)=7.127,P<0.05).Conclusion In the clinical application of intravitreal injection of Conbercept for the treatment of patients with retinal vein occlusion,targeted care can be given to obtain better results and is worthy of promotion and application.